Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19

Ozlem Altay, Hong Yang, Mehtap Aydin, Gizem Alkurt, L. Nilsun Altunal, Woonghee Kim, Dogukan Akyol, Muhammad Arif, Cheng Zhang, Gizem Dinler-Doganay, Hasan Turkez, Saeed Shoaie, Jens Nielsen, Jan Borén, Levent Doganay, Mathias Uhlén, Adil Mardinoglu
doi: https://doi.org/10.1101/2020.10.02.20202614
Ozlem Altay
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
2Department of Clinical Microbiology, Dr. Sami Ulus Training and Research Hospital, University of Health Sciences, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Yang
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehtap Aydin
3Department of Infectious Diseases, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gizem Alkurt
4Genomic Laboratory (GLAB), Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Nilsun Altunal
3Department of Infectious Diseases, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Woonghee Kim
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dogukan Akyol
4Genomic Laboratory (GLAB), Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Arif
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng Zhang
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
5School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gizem Dinler-Doganay
6Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hasan Turkez
7Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saeed Shoaie
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
8Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Nielsen
9Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Borén
10Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levent Doganay
11Department of Gastroenterology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Uhlén
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adil Mardinoglu
1Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
8Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: adilm@scilifelab.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND The characteristics of COVID-19 outbreak and high fatality rate of COVID□19 infection have attracted the attention of scientists due to the strong interactions between components of metabolic syndrome, metabolic abnormalities, and viral pathobiology of COVID-19. Combined metabolic cofactors supplementation (CMCS) consisting of L-serine, N-acetyl-L-cysteine (NAC), nicotinamide riboside (NR), and L-carnitine tartrate is being studied for the treatment of patients with COVID-19.

METHODS We conducted a placebo-controlled, phase-2 clinical trial involving ambulatory COVID-19 patients. A total of 100 patients were randomly assigned on a 3:1 basis to hydroxychloroquine plus CMCS or hydroxychloroquine plus placebo. The total treatment period for the hydroxychloroquine was 5 days, and for the CMCS/placebo was 14 days. Clinical status was evaluated daily by phone, using a binomial scale for subject reported presence or absence for multiple COVID-19 related symptoms. Plasma samples for clinical chemistry analyses were collected on day 0 and day 14.

RESULTS A total of 93 patients completed the trial. The combination of CMCS and hydroxychloroquine significantly reduced the average complete recovery time compared with hydroxychloroquine and placebo (6.6 days vs 9.3 days, respectively). Moreover, there was a significant reduction in ALT, AST and LDH levels on day 14 compared to day 0 in the hydroxychloroquine plus CMCS group. The adverse effects were uncommon and self-limiting.

CONCLUSIONS In patients with mild-to-moderate COVID-19, CMCS resulted in a significant reduction in recovery time and liver enzymes associated with hepatic function compared to placebo. We observed that CMSC is associated with a low incidence of adverse events.

Competing Interest Statement

AM, JB and MU filed a patent application on the use of CMCS on COVID-19 patients. The other authors declare no competing interests.

Clinical Trial

ClinicalTrials.gov NCT04573153

Funding Statement

This work was supported by Knut and Alice Wallenberg Foundation. The authors would like to thank ChromaDex (Irvine, CA, USA) for providing NR for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study has been approved by the ethics committee of Istanbul Medipol University. Decision No:45 Decision Date: 28/05/2020 Members of Ethics Committee: Professor Hanefi OZBEK Professor Gurkan OZTURK Professor Fulya IlCin GONENC Professor Abdulbari BENER Associate Professor Ali OZTURK Associate Professor Bahri TEKER Associate Professor Muhammed Fatih EVCIMIK

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Emails: havva.altay{at}scilifelab.se; hong.yang{at}scilifelab.se; mehtapaydin10{at}gmail.com; alkurt.gizem{at}gmail.com; l.nilsun{at}hotmail.com; woonghee.kim{at}scilifelab.se; akyol_dogukan{at}hotmail.com; muhammad.arif{at}scilifelab.se; cheng.zhang{at}scilifelab.se; gddoganay{at}itu.edu.tr; hturkez{at}atauni.edu.tr; saeed.shoaie{at}kcl.ac.uk; nielsenj{at}chalmers.se; jan.boren{at}wlab.gu.se; levent.doganay{at}saglik.gov.tr; mathias.uhlen{at}scilifelab.se; adilm{at}scilifelab.se

Data Availability

The data that support the findings of this study are available from the corresponding author [adilm@scilifelab.se], upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19
Ozlem Altay, Hong Yang, Mehtap Aydin, Gizem Alkurt, L. Nilsun Altunal, Woonghee Kim, Dogukan Akyol, Muhammad Arif, Cheng Zhang, Gizem Dinler-Doganay, Hasan Turkez, Saeed Shoaie, Jens Nielsen, Jan Borén, Levent Doganay, Mathias Uhlén, Adil Mardinoglu
medRxiv 2020.10.02.20202614; doi: https://doi.org/10.1101/2020.10.02.20202614
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19
Ozlem Altay, Hong Yang, Mehtap Aydin, Gizem Alkurt, L. Nilsun Altunal, Woonghee Kim, Dogukan Akyol, Muhammad Arif, Cheng Zhang, Gizem Dinler-Doganay, Hasan Turkez, Saeed Shoaie, Jens Nielsen, Jan Borén, Levent Doganay, Mathias Uhlén, Adil Mardinoglu
medRxiv 2020.10.02.20202614; doi: https://doi.org/10.1101/2020.10.02.20202614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)